TP53 and neoplasm: The low-risk group showed less tumor mutation burden (TMB) than the high-risk group, while some of the top ten most significantly mutated genes, such as APC, TP53 and FAT4, showed higher TMB in the low-risk group (Supplementary Figure 5C).